Tower Research Capital LLC (Trc) Avadel Pharmaceuticals PLC Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$12.55 - $17.22 $21,837 - $29,962	-1,740 Reduced 67.65%	832 $14,000
Q4 2023 Feb 13, 2024	SELL	$9.64 - $14.59 $115,149 - $174,277	-11,945 Reduced 82.28%	2,572 $36,000
Q3 2023 Nov 14, 2023	BUY	$10.3 - $15.99 $99,982 - $155,214	9,707 Added 201.81%	14,517 $149,000
Q2 2023 Aug 14, 2023	BUY	$8.48 - $16.48 $8,106 - $15,754	956 Added 24.81%	4,810 $79,000
Q1 2023 May 09, 2023	SELL	$6.41 - $9.95 $15,358 - $23,840	-2,396 Reduced 38.34%	3,854 $35,000
Q4 2022 Feb 10, 2023	SELL	$5.02 - $10.0 $40,732 - $81,140	-8,114 Reduced 56.49%	6,250 $45,000
Q3 2022 Nov 10, 2022	BUY	$2.57 - $7.31 $25,949 - $73,809	10,097 Added 236.63%	14,364 $72,000
Q2 2022 Aug 15, 2022	BUY	$1.07 - $6.95 $81 - $528	76 Added 1.81%	4,267 $10,000
Q1 2022 May 12, 2022	SELL	$5.46 - $8.29 $85,061 - $129,149	-15,579 Reduced 78.8%	4,191 $29,000
Q4 2021 Feb 14, 2022	BUY	$7.34 - $11.18 $100,469 - $153,031	13,688 Added 225.06%	19,770 $159,000
Q3 2021 Nov 15, 2021	SELL	$6.49 - $9.91 $15,673 - $23,932	-2,415 Reduced 28.42%	6,082 $60,000
Q2 2021 Aug 16, 2021	BUY	$6.73 - $9.05 $37,216 - $50,046	5,530 Added 186.38%	8,497 $58,000
Q1 2021 May 17, 2021	SELL	$6.61 - $10.07 $81,164 - $123,649	-12,279 Reduced 80.54%	2,967 $27,000
Q4 2020 Feb 16, 2021	BUY	$5.03 - $7.95 $21,674 - $34,256	4,309 Added 39.4%	15,246 $102,000
Q3 2020 Nov 16, 2020	BUY	$5.02 - $8.98 $54,903 - $98,214	10,937 New	10,937 $55,000
Q4 2019 Feb 07, 2020	SELL	$3.34 - $7.7 $2,555 - $5,890	-765 Closed	0 $0
Q3 2019 Nov 05, 2019	SELL	$1.92 - $4.47 $3,550 - $8,265	-1,849 Reduced 70.73%	765 $3,000
Q2 2019 Aug 13, 2019	BUY	$1.09 - $3.19 $2,677 - $7,834	2,456 Added 1554.43%	2,614 $8,000
Q1 2019 May 14, 2019	SELL	$1.44 - $3.29 $25 - $59	-18 Reduced 10.23%	158 $0
Q4 2018 Feb 14, 2019	BUY	$1.74 - $4.66 $306 - $820	176 New	176 $0
Q2 2018 Aug 15, 2018	SELL	$5.89 - $7.78 $57,368 - $75,777	-9,740 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$6.76 - $11.7 $64,605 - $111,816	9,557 Added 5222.4%	9,740 $71,000
Q4 2017 Feb 09, 2018	SELL	$8.03 - $11.25 $24,114 - $33,783	-3,003 Reduced 94.26%	183 $2,000
Q3 2017 Nov 14, 2017	BUY	$8.35 - $10.5 $26,603 - $33,453	3,186	3,186 $33,000

Others Institutions Holding AVDL

# of Institutions

Shares Held

1.07M

Call Options Held

Put Options Held

View Full List

About AVADEL PHARMACEUTICALS PLC

Ticker AVDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,581,300
Market Cap $650M
Description
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...

More about AVDL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account